Annual Revenue
$361.05 M
+$64.52 M+21.76%
31 December 2023
Summary:
Veracyte annual revenue is currently $361.05 million, with the most recent change of +$64.52 million (+21.76%) on 31 December 2023. During the last 3 years, it has risen by +$141.54 million (+64.48%). VCYT annual revenue is now at all-time high.VCYT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$115.86 M
+$1.43 M+1.25%
30 September 2024
Summary:
Veracyte quarterly revenue is currently $115.86 million, with the most recent change of +$1.43 million (+1.25%) on 30 September 2024. Over the past year, it has increased by +$17.66 million (+17.98%). VCYT quarterly revenue is now at all-time high.VCYT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$425.33 M
+$25.75 M+6.44%
30 September 2024
Summary:
Veracyte TTM revenue is currently $425.33 million, with the most recent change of +$25.75 million (+6.44%) on 30 September 2024. Over the past year, it has increased by +$64.28 million (+17.80%). VCYT TTM revenue is now at all-time high.VCYT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCYT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +18.0% | +17.8% |
| 3 y3 years | +64.5% | +72.1% | +93.8% |
| 5 y5 years | +200.0% | +289.7% | +253.4% |
VCYT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.5% | at high | +72.1% | at high | +93.8% |
| 5 y | 5 years | at high | +207.3% | at high | +459.6% | at high | +278.0% |
| alltime | all time | at high | >+9999.0% | at high | +3493.7% | at high | >+9999.0% |
Veracyte Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $115.86 M(+1.3%) | $425.33 M(+6.4%) |
| June 2024 | - | $114.43 M(+18.2%) | $399.58 M(+6.4%) |
| Mar 2024 | - | $96.84 M(-1.4%) | $375.47 M(+4.0%) |
| Dec 2023 | $361.05 M(+21.8%) | $98.20 M(+9.0%) | $361.05 M(+5.2%) |
| Sept 2023 | - | $90.11 M(-0.2%) | $343.15 M(+4.4%) |
| June 2023 | - | $90.32 M(+9.6%) | $328.63 M(+5.6%) |
| Mar 2023 | - | $82.42 M(+2.6%) | $311.18 M(+4.9%) |
| Dec 2022 | $296.54 M(+35.1%) | $80.30 M(+6.2%) | $296.54 M(+4.6%) |
| Sept 2022 | - | $75.59 M(+3.7%) | $283.57 M(+5.7%) |
| June 2022 | - | $72.86 M(+7.5%) | $268.35 M(+7.1%) |
| Mar 2022 | - | $67.78 M(+0.7%) | $250.59 M(+14.2%) |
| Dec 2021 | $219.51 M(+86.8%) | $67.34 M(+11.5%) | $219.51 M(+17.6%) |
| Sept 2021 | - | $60.37 M(+9.6%) | $186.71 M(+18.6%) |
| June 2021 | - | $55.10 M(+50.1%) | $157.47 M(+28.0%) |
| Mar 2021 | - | $36.70 M(+6.3%) | $123.06 M(+4.8%) |
| Dec 2020 | $117.48 M(-2.4%) | $34.54 M(+11.0%) | $117.48 M(+4.3%) |
| Sept 2020 | - | $31.12 M(+50.3%) | $112.68 M(+0.1%) |
| June 2020 | - | $20.70 M(-33.5%) | $112.53 M(-7.7%) |
| Mar 2020 | - | $31.12 M(+4.7%) | $121.96 M(+1.3%) |
| Dec 2019 | $120.37 M(+30.8%) | $29.73 M(-4.0%) | $120.37 M(+3.4%) |
| Sept 2019 | - | $30.97 M(+2.8%) | $116.39 M(+6.9%) |
| June 2019 | - | $30.14 M(+2.1%) | $108.88 M(+7.3%) |
| Mar 2019 | - | $29.53 M(+14.7%) | $101.50 M(+10.3%) |
| Dec 2018 | $92.01 M | $25.75 M(+9.7%) | $92.01 M(+7.2%) |
| Sept 2018 | - | $23.47 M(+3.1%) | $85.85 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $22.75 M(+13.5%) | $79.91 M(+5.8%) |
| Mar 2018 | - | $20.04 M(+2.3%) | $75.56 M(+5.0%) |
| Dec 2017 | $71.95 M(+10.6%) | $19.60 M(+11.9%) | $71.95 M(+1.9%) |
| Sept 2017 | - | $17.52 M(-4.8%) | $70.61 M(-1.5%) |
| June 2017 | - | $18.41 M(+12.0%) | $71.70 M(+5.5%) |
| Mar 2017 | - | $16.43 M(-10.0%) | $67.97 M(+4.4%) |
| Dec 2016 | $65.08 M(+31.5%) | $18.26 M(-1.9%) | $65.08 M(+6.9%) |
| Sept 2016 | - | $18.60 M(+26.8%) | $60.87 M(+11.5%) |
| June 2016 | - | $14.68 M(+8.3%) | $54.60 M(+5.3%) |
| Mar 2016 | - | $13.55 M(-3.5%) | $51.84 M(+4.7%) |
| Dec 2015 | $49.50 M(+29.6%) | $14.04 M(+13.8%) | $49.50 M(+3.9%) |
| Sept 2015 | - | $12.34 M(+3.6%) | $47.66 M(+5.5%) |
| June 2015 | - | $11.91 M(+6.2%) | $45.16 M(+7.7%) |
| Mar 2015 | - | $11.22 M(-8.0%) | $41.93 M(+9.8%) |
| Dec 2014 | $38.19 M(+74.5%) | $12.20 M(+24.0%) | $38.19 M(+16.3%) |
| Sept 2014 | - | $9.84 M(+13.4%) | $32.83 M(+14.8%) |
| June 2014 | - | $8.68 M(+16.1%) | $28.59 M(+14.4%) |
| Mar 2014 | - | $7.48 M(+9.3%) | $24.98 M(+14.1%) |
| Dec 2013 | $21.88 M(+88.2%) | $6.84 M(+22.2%) | $21.88 M(+12.2%) |
| Sept 2013 | - | $5.59 M(+10.4%) | $19.50 M(+13.8%) |
| June 2013 | - | $5.07 M(+15.6%) | $17.13 M(+42.0%) |
| Mar 2013 | - | $4.38 M(-1.6%) | $12.06 M(+57.1%) |
| Dec 2012 | $11.63 M(+339.6%) | $4.46 M(+38.2%) | $7.68 M(+138.2%) |
| Sept 2012 | - | $3.22 M | $3.22 M |
| Dec 2011 | $2.65 M | - | - |
FAQ
- What is Veracyte annual revenue?
- What is the all time high annual revenue for Veracyte?
- What is Veracyte quarterly revenue?
- What is the all time high quarterly revenue for Veracyte?
- What is Veracyte quarterly revenue year-on-year change?
- What is Veracyte TTM revenue?
- What is the all time high TTM revenue for Veracyte?
- What is Veracyte TTM revenue year-on-year change?
What is Veracyte annual revenue?
The current annual revenue of VCYT is $361.05 M
What is the all time high annual revenue for Veracyte?
Veracyte all-time high annual revenue is $361.05 M
What is Veracyte quarterly revenue?
The current quarterly revenue of VCYT is $115.86 M
What is the all time high quarterly revenue for Veracyte?
Veracyte all-time high quarterly revenue is $115.86 M
What is Veracyte quarterly revenue year-on-year change?
Over the past year, VCYT quarterly revenue has changed by +$17.66 M (+17.98%)
What is Veracyte TTM revenue?
The current TTM revenue of VCYT is $425.33 M
What is the all time high TTM revenue for Veracyte?
Veracyte all-time high TTM revenue is $425.33 M
What is Veracyte TTM revenue year-on-year change?
Over the past year, VCYT TTM revenue has changed by +$64.28 M (+17.80%)